Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Armata Pharmaceuticals ( (ARMP) ) has provided an update.
Armata Pharmaceuticals has scheduled its 2026 annual meeting of stockholders for June 11, 2026, at 8:30 a.m. Pacific Time at its principal executive offices in Los Angeles, California, with the meeting date and venue potentially subject to change by the board of directors. Stockholders of record as of the close of business on April 17, 2026, will be entitled to receive notice of the meeting and vote on matters presented.
The company set April 12, 2026, at 5:00 p.m. Pacific Time as the deadline for receiving stockholder proposals and director nominations under its amended and restated bylaws, requiring written submissions to the corporate secretary at its Los Angeles headquarters. These procedural details clarify the timeline and requirements for shareholder participation in governance and may influence how actively investors engage in shaping the company’s board and agenda at the 2026 meeting.
The most recent analyst rating on (ARMP) stock is a Hold with a $8.50 price target. To see the full list of analyst forecasts on Armata Pharmaceuticals stock, see the ARMP Stock Forecast page.
Spark’s Take on ARMP Stock
According to Spark, TipRanks’ AI Analyst, ARMP is a Neutral.
The score is held down primarily by weak financial performance (ongoing losses, cash burn, and negative equity). Technicals are mixed with soft momentum but some oversold signals, while valuation provides limited support due to negative earnings. Offsetting these risks, recent corporate events are meaningfully positive, highlighted by Phase 3 pathway support and QIDP designation for the lead program.
To see Spark’s full report on ARMP stock, click here.
More about Armata Pharmaceuticals
Armata Pharmaceuticals, Inc. is a biotechnology company focused on developing therapeutic solutions, and its stock is held by public investors who participate in corporate governance through annual stockholder meetings. The company operates from its principal executive offices in Los Angeles, California, where it conducts its business and hosts key corporate events, including its annual meeting of stockholders.
Average Trading Volume: 47,864
Technical Sentiment Signal: Buy
Current Market Cap: $386.8M
Find detailed analytics on ARMP stock on TipRanks’ Stock Analysis page.